FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170189969> ?p ?o ?g. }

• W2170189969 endingPage "545" @default.
• W2170189969 startingPage "535" @default.
• W2170189969 abstract "Edoxaban is an oral, reversible, direct factor Xa inhibitor in phase III clinical development for the prevention of stroke in atrial fibrillation (AF). A phase II study was undertaken to evaluate the safety and efficacy of edoxaban in Asian patients with non-valvular AF with CHADS2 score ≥1. In a multicentre, active-controlled, double-blind edoxaban and open-label warfarin, parallel-group study, a total of 235 patients from four Asian countries were randomly assigned to edoxaban 30 mg qd, 60 mg qd or warfarin dose adjusted to international normalised ratio of 2-3 for three months. The primary endpoint was the incidence of centrally adjudicated all bleeding events (major, clinically relevant non-major and minor). Secondary endpoints included thromboembolic events, biomarkers of thrombus formation and all adverse events (AEs). The incidence of all bleeding events (95% CI) was 20.3% (12.9, 30.4) for edoxaban 30 mg, 23.8% (15.8, 34.1) for edoxaban 60 mg, and 29.3% (20.2, 40.4) for warfarin. A subgroup analysis suggested low body weight (≤60 kg) may affect the incidence of bleeding events with edoxaban. The incidence of study drug-related AEs was 22% for edoxaban 30 mg, 29% for edoxaban 60 mg and 33% for warfarin. No thromboembolic events occurred in any treatment group. In conclusion, this phase II study found a trend for a reduction in the incidence of all bleeding events in Asian AF patients with edoxaban 30 mg and 60 mg compared with warfarin. Adverse events were similar between the edoxaban 60-mg and warfarin groups and were lower with the edoxaban 30-mg group." @default.
• W2170189969 created "2016-06-24" @default.
• W2170189969 creator A5032895664 @default.
• W2170189969 creator A5033147236 @default.
• W2170189969 creator A5034206287 @default.
• W2170189969 creator A5051627611 @default.
• W2170189969 creator A5057956173 @default.
• W2170189969 creator A5061176033 @default.
• W2170189969 creator A5070376025 @default.
• W2170189969 creator A5078963207 @default.
• W2170189969 date "2011-01-01" @default.
• W2170189969 modified "2023-10-13" @default.
• W2170189969 title "Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation" @default.
• W2170189969 cites W1586488555 @default.
• W2170189969 cites W1967046500 @default.
• W2170189969 cites W1997637512 @default.
• W2170189969 cites W2006269130 @default.
• W2170189969 cites W2012044604 @default.
• W2170189969 cites W2013966095 @default.
• W2170189969 cites W2022095549 @default.
• W2170189969 cites W2027735039 @default.
• W2170189969 cites W2060630424 @default.
• W2170189969 cites W2062786076 @default.
• W2170189969 cites W2070567676 @default.
• W2170189969 cites W2084988042 @default.
• W2170189969 cites W2087435181 @default.
• W2170189969 cites W2096913021 @default.
• W2170189969 cites W2105486760 @default.
• W2170189969 cites W2132505348 @default.
• W2170189969 cites W2144582288 @default.
• W2170189969 cites W2146272590 @default.
• W2170189969 cites W2151074096 @default.
• W2170189969 cites W2744079636 @default.
• W2170189969 doi "https://doi.org/10.1160/th10-07-0451" @default.
• W2170189969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21136011" @default.
• W2170189969 hasPublicationYear "2011" @default.
• W2170189969 type Work @default.
• W2170189969 sameAs 2170189969 @default.
• W2170189969 citedByCount "98" @default.
• W2170189969 countsByYear W21701899692012 @default.
• W2170189969 countsByYear W21701899692013 @default.
• W2170189969 countsByYear W21701899692014 @default.
• W2170189969 countsByYear W21701899692015 @default.
• W2170189969 countsByYear W21701899692016 @default.
• W2170189969 countsByYear W21701899692017 @default.
• W2170189969 countsByYear W21701899692018 @default.
• W2170189969 countsByYear W21701899692019 @default.
• W2170189969 countsByYear W21701899692020 @default.
• W2170189969 countsByYear W21701899692021 @default.
• W2170189969 countsByYear W21701899692022 @default.
• W2170189969 countsByYear W21701899692023 @default.
• W2170189969 crossrefType "journal-article" @default.
• W2170189969 hasAuthorship W2170189969A5032895664 @default.
• W2170189969 hasAuthorship W2170189969A5033147236 @default.
• W2170189969 hasAuthorship W2170189969A5034206287 @default.
• W2170189969 hasAuthorship W2170189969A5051627611 @default.
• W2170189969 hasAuthorship W2170189969A5057956173 @default.
• W2170189969 hasAuthorship W2170189969A5061176033 @default.
• W2170189969 hasAuthorship W2170189969A5070376025 @default.
• W2170189969 hasAuthorship W2170189969A5078963207 @default.
• W2170189969 hasBestOaLocation W21701899692 @default.
• W2170189969 hasConcept C120665830 @default.
• W2170189969 hasConcept C121332964 @default.
• W2170189969 hasConcept C126322002 @default.
• W2170189969 hasConcept C164705383 @default.
• W2170189969 hasConcept C168563851 @default.
• W2170189969 hasConcept C197934379 @default.
• W2170189969 hasConcept C203092338 @default.
• W2170189969 hasConcept C2776301958 @default.
• W2170189969 hasConcept C2778661090 @default.
• W2170189969 hasConcept C2779161974 @default.
• W2170189969 hasConcept C2780290652 @default.
• W2170189969 hasConcept C61511704 @default.
• W2170189969 hasConcept C71924100 @default.
• W2170189969 hasConcept C90924648 @default.
• W2170189969 hasConceptScore W2170189969C120665830 @default.
• W2170189969 hasConceptScore W2170189969C121332964 @default.
• W2170189969 hasConceptScore W2170189969C126322002 @default.
• W2170189969 hasConceptScore W2170189969C164705383 @default.
• W2170189969 hasConceptScore W2170189969C168563851 @default.
• W2170189969 hasConceptScore W2170189969C197934379 @default.
• W2170189969 hasConceptScore W2170189969C203092338 @default.
• W2170189969 hasConceptScore W2170189969C2776301958 @default.
• W2170189969 hasConceptScore W2170189969C2778661090 @default.
• W2170189969 hasConceptScore W2170189969C2779161974 @default.
• W2170189969 hasConceptScore W2170189969C2780290652 @default.
• W2170189969 hasConceptScore W2170189969C61511704 @default.
• W2170189969 hasConceptScore W2170189969C71924100 @default.
• W2170189969 hasConceptScore W2170189969C90924648 @default.
• W2170189969 hasIssue "03" @default.
• W2170189969 hasLocation W21701899691 @default.
• W2170189969 hasLocation W21701899692 @default.
• W2170189969 hasLocation W21701899693 @default.
• W2170189969 hasOpenAccess W2170189969 @default.
• W2170189969 hasPrimaryLocation W21701899691 @default.
• W2170189969 hasRelatedWork W131995492 @default.
• W2170189969 hasRelatedWork W2129599703 @default.
• W2170189969 hasRelatedWork W2302042514 @default.

• next